Page 13 - 2018 SP Product Guide

Our commitment

To research
Saligesic and Cramplex:
We are a global leader in herbal scientific
knowledge and often partner on research projects working together on
to advance quality and efficacy with reputable clinical feedback trials
establishments. Our outstanding team of scientists
and health care professionals drive our research, Our clinical feedback trials involve our
development and quality control practices. We also network of health care professionals in
collaborate with health care professionals for
real-time patient feedback. Significant innovations the development and validation of new
include our revolutionary process of manufacturing products prior to launch. By working
herbal tablets from liquid extracts and 1:2 Cold together, we are able to gather valid clinical
Echinacea: the landmark Percolation manufacturing process. Our Research data in a timely and cost-effective manner.
research project and Development team combine experience in Feedback trials completed for Saligesic
food and herbal products, university research, drug
analysis in hospitals, pharmaceuticals, quality (a highly potent Willow Bark product for
The most well-known herbal support assurance, technical writing, clinical nutrition and exercise-related lower back pain) and
for the immune system is Echinacea, work in situ with our own herbalists and Cramplex (a formulated product for the
yet it is both misunderstood and naturopaths, along with a board of leading relief of mild discomfort associated with
underestimated. There are many American, Australian and other international menstruation) prior to their launch helped
Echinacea products available, which herbalists. This ensures we can combine the best us clearly demonstrate their efficacy.*
differ according to plant species, plant of science, traditional knowledge and current
clinical knowledge to produce the most efficacious
part (root, leaves, seeds or a herbal and nutritional solutions. Saligesic Feedback Trial Results
combination), quality markers and 15
dosage. In 2003, MediHerb began an To innovation 12
®
extensive research project designed to Innovation is the lifeblood of our business and
identify the bioavailable components supports our culture of excellence. We undertake 9
of Echinacea Premium and how they a rigorous new product development process to 6
exert an effect on the immune system. ensure that appropriate steps are undertaken
MediHerb research results made a when investigating the introduction of a new 3
®
product. This allows us to develop a shortlist of key
substantial contribution to a new herbs that are then subjected to closer analysis.
understanding of lipophilic extracts of This involves detailed examination of the clinical 0 0 week 3 week 6 week
Echinacea, which conclude that outcomes, phytochemistry and biological activity,
alkylamides must be used as the analytical methodology, continuity of supply, 8 Cramplex Feedback Trial Results
markers of quality and activity, the root economic sustainability, synergy of the final 7
formula, cost to the patient and practicality of final
of Echinacea is the preferred plant part dose formulation. Once the prototype formulation 6
given its high levels of alkylamides and is agreed upon, we may then undertake a human 5
the preferred species of Echinacea are feedback trial to prove the efficacy and safety of
E. angustifolia and E. purpurea since they the product and regularly supply product to 4
contain high levels of alkylamides. In support other industry research projects. 3
addition, our research has proven that 2
Echinacea must be extracted using an 1
alcohol percentage sufficiently high to 0 Prior First Second
efficiently extract the alkylamides.* to trial menstrual menstrual
cycle
cycle
Worst Background Intervention
Pain Pain Usage
12 MediHerb Product Catalog 2018 • Our philosophy
®